Connect with us
Biotechnology stocks have had their fair share of bumps and bruises after heavy concern surrounding pricing was brought up by several presidential candidates during the first...
Over the past few months, the biotech sector saw a large sell-off ignited by pricing worries. Democratic Presidential candidate Hillary Clinton’s “price gouging” tweet she posted...
In the U.S., healthcare spending is now approximately 17% of gross domestic product (GDP). In the middle of an economic recovery, healthcare costs are growing double...
Though weakness in China, volatile commodity prices and increasing concerns over the health of the U.S. economy have had an opposing impact on capital markets and...
On Wednesday Richmond Federal Reserve President Jeffrey Lacker stated a brief occurrence of upsetting economic information that has done little to alter his outlook for the...